Bristol Myers Squibb (BMY) in the Warm zone: what does the evidence show?
Bristol Myers Squibb (BMY) has a Therm Score of 62.14 today, in the Warm zone. Across the full covered universe (S&P 500, Dow 30 and Nasdaq-100 — 520 assets), when the score has been in this zone, price has risen over the following 21 sessions in 90.9% of the independent episodes analyzed (median: +2.59%, net of trading costs, n=11 episodes).
This reflects aggregate historical behavior across the covered universe, not a prediction specific to Bristol Myers Squibb (BMY). Score calculated on September 5, 2026 using institutional market data, updated daily.
The chart above shows Bristol Myers Squibb (BMY)'s own history. The statistical validation cited in the text is based on the covered universe as a whole (S&P 500, Dow 30, Nasdaq-100 — 520 assets), not on this asset in isolation.
About Bristol Myers Squibb
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio.
Health Care peers
Other Health Care assets in the covered universe, by Therm Score today — not a recommendation, just context.
Recent news about Bristol Myers Squibb (BMY)
Frequently asked questions about Bristol Myers Squibb (BMY)
Is now a good time to buy Bristol Myers Squibb (BMY)?+
The Therm Score doesn't give buy or sell recommendations — it's non-personalized historical statistical information. Today Bristol Myers Squibb (BMY) has a Therm Score of 62.1 (Warm zone); the covered universe shows what has historically happened when the indicator has scored similarly. This doesn't replace professional financial advice or account for your personal situation.
What is the price prediction for Bristol Myers Squibb (BMY)?+
This tool doesn't make price predictions or set price targets. Instead, it shows the historical frequency with which price has risen or fallen after a similar score — across the covered universe as a whole, not a specific forecast for Bristol Myers Squibb (BMY).
Is Bristol Myers Squibb (BMY) overbought or oversold?+
According to the Therm Score, Bristol Myers Squibb (BMY) is in the Warm zone today (62.1/100), based on normalized technical positioning relative to its own historical range.
Is Bristol Myers Squibb (BMY) a good long-term investment?+
The Therm Score measures short-to-medium-term technical positioning (horizons of 5 to 21 sessions) — it isn't a fundamental analysis tool and doesn't assess Bristol Myers Squibb's quality as a long-term investment.
Can I trust this indicator to invest?+
It's based on a validated historical backtest across the covered universe, with controls to avoid overfitting — but like any indicator based on past data, it doesn't guarantee future results.
How often is the Bristol Myers Squibb (BMY) Therm Score updated?+
The score is recalculated every day after market close, using the most recent closing data available.